Leaked treaty is a Hollywood wish list. Could it derail Obamas trade agenda?
Key Excerpts from Article on Website of Washington Post Blog
Posted: November 23rd, 2014
Officially, the Trans-Pacific Partnership is a trade treaty that will ease the flow of goods and services among the United States ... and other nations along the Pacific Rim. But it has attracted criticism for its secrecy, and for the inclusion of controversial provisions related to copyright, patent, and trademark protections. Wikileaks released an August draft of the "intellectual property" chapter of the treaty. The United States has been using the treaty as a vehicle to pressure its negotiating partners to make their laws more favorable to the interests of U.S. filmmakers, drug companies, and other large holders of copyright and patent rights. Several proposed items are drawn from Hollywood's wish list. The United States has also pushed for a wide variety of provisions that would benefit the U.S. pharmaceutical and medical device industries. The Obama administration wants to require the extension of patent protection to plants, animals, and medical procedures. It wants to require countries to offer longer terms of patent protection to compensate for delays in the patent application process. The United States also wants to bar the manufacturers of generic drugs from relying on safety and efficacy information that was previously submitted by a brand-name drug maker a step that would make it harder for generic manufacturers to enter the pharmaceutical market and could raise drug prices.
Note: Why was this vitally important, yet little-reported news relegated to a blog? Read an October, 2014 update on the secret trade deal in The Guardian (One of the UK's leading newspapers). The Environment Chapter of the TPP has also been leaked. For more along these lines, see these concise summaries of deeply revealing articles about government secrecy.